Full Year 2023 Pacific Edge Ltd Earnings Call Transcript
Good morning, everybody, and welcome to the Pacific Edge results presentation for FY '23. I'm Dr. Peter Meintjes, the CEO of Pacific Edge. And with me today is Grant Gibson, our CFO. And in the room here with me are two of our Board members, Sarah Park and Anna Stove, with our Chairman, Chris Gallaher, joining remotely from Melbourne. Just as a reminder, by participating on this call, you agree and understand to all of the terms and conditions on this slide.
So moving quickly to our highlights. Global testing volumes are up 37%. Commercial volumes are up 39%. Growth in operating revenue, up 71%. This does come with a net loss after tax of $27 million, but we remain with a healthy cash balance of $77.8 million.
Qualitatively, when we summarize this year, we are focused on a year of strategic delivery. And obviously, we're very impressed -- I've been very impressed by the team for delivering strong results in the key U.S. market with a rise of 44% to get to 27,217 tests for the year. Behind that is an increase in the number of ordering clinicians
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |